Helicobacter pylori virulence factors and the host immune response:: implications for therapeutic vaccination

被引：57

作者：

Prinz, C ^{[1
]}

Hafsi, N ^{[1
]}

Voland, P ^{[1
]}

机构：

[1] Tech Univ Munich, Dept Med 2, D-81675 Munich, Germany

来源：

TRENDS IN MICROBIOLOGY | 2003年 / 11卷 / 03期

关键词：

D O I：

10.1016/S0966-842X(03)00024-6

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Helicobacter pylori colonizes the human gastric mucosa and is associated with specific gastric disease. Virulence factors, such as urease, the vacuolating toxin (VacA), the cytotoxin-associated antigen CagA or blood-group-antigen-binding adhesin (BabA), an adherence factor, might account for the development of different diseases. Vaccination trials exploiting the antigenic properties of some of these proteins have not been successful in preventing infection in humans. A more in-depth understanding of the immune response to H. pylori infection as well as additional information on suitable epitopes and adjuvants will be required before a successful vaccine can be developed.

引用

收藏

页码：134 / 138

页数：5

相关论文

共 49 条

[1] Comparative genomics of Helicobacter pylori:: Analysis of the outer membrane protein families [J].

Alm, RA ;

Bina, J ;

Andrews, BM ;

Doig, P ;

Hancock, REW ;

Trust, TJ .

INFECTION AND IMMUNITY, 2000, 68 (07) :4155-4168

[2] Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers [J].

Angelakopoulos, H ;

Hohmann, EL .

INFECTION AND IMMUNITY, 2000, 68 (04) :2135-2141

[3] Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori [J].

Atherton, JC ;

Peek, RM ;

Tham, KT ;

Cover, TL ;

Blaser, MJ .

GASTROENTEROLOGY, 1997, 112 (01) :92-99

[4] Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs [J].

Ballas, ZK ;

Krieg, AM ;

Warren, T ;

Rasmussen, W ;

Davis, HL ;

Waldschmidt, M ;

Weiner, GJ .

JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4878-4886

[5]

Blanchard TG, 1999, CURR TOP MICROBIOL, V241, P181

[6]

Blaser M J, 1993, Trends Microbiol, V1, P255, DOI 10.1016/0966-842X(93)90047-U

[7] Helicobacter pylori:: Epidemiology and routes of transmission [J].

Brown, LM .

EPIDEMIOLOGIC REVIEWS, 2000, 22 (02) :283-297

[8] Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers [J].

Bumann, D ;

Metzger, WG ;

Mansouri, E ;

Palme, O ;

Wendland, M ;

Hurwitz, R ;

Haas, G ;

Aebischer, T ;

von Specht, BU ;

Meyer, TF .

VACCINE, 2001, 20 (5-6) :845-852

[9] The Helicobacter pylori Urel protein:: role in adaptation to acidity and identification of residues essential for its activity and for acid activation [J].

Bury-Moné, S ;

Skouloubris, S ;

Labigne, A ;

De Reuse, H .

MOLECULAR MICROBIOLOGY, 2001, 42 (04) :1021-1034

[10] cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors [J].

Censini, S ;

Lange, C ;

Xiang, ZY ;

Crabtree, JE ;

Ghiara, P ;

Borodovsky, M ;

Rappuoli, R ;

Covacci, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14648-14653

← 1 2 3 4 5 →